Australia markets close in 28 minutes

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1700-0.0050 (-2.86%)
As of 03:23PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 353.29M
Enterprise value 309.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)28.01
Price/book (mrq)5.80
Enterprise value/revenue 27.47
Enterprise value/EBITDA -15.08

Trading information

Stock price history

Beta (5Y monthly) 2.99
52-week change 3182.26%
S&P500 52-week change 314.91%
52-week high 30.2400
52-week low 30.0560
50-day moving average 30.1904
200-day moving average 30.1309

Share statistics

Avg vol (3-month) 33.02M
Avg vol (10-day) 31.14M
Shares outstanding 52.02B
Implied shares outstanding 62.02B
Float 81.76B
% held by insiders 112.87%
% held by institutions 113.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin -180.90%
Operating margin (ttm)-201.56%

Management effectiveness

Return on assets (ttm)-22.43%
Return on equity (ttm)-36.67%

Income statement

Revenue (ttm)11.34M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)9.8M
EBITDA -22.19M
Net income avi to common (ttm)-20.52M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.71M
Total cash per share (mrq)0.02
Total debt (mrq)1.45M
Total debt/equity (mrq)2.38%
Current ratio (mrq)8.88
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-18.05M
Levered free cash flow (ttm)-18.82M